Canaccord cuts Veracyte stock price target to $50 on revenue outlook

Markets Investing.com By Investing.com 03 Aug 2026 10:38 1 min read

Covered in this story

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.